Contribution of plasmablasts in the conversion of transverse myelitis to multiple sclerosis
浆母细胞在横贯性脊髓炎转化为多发性硬化症中的作用
基本信息
- 批准号:10132408
- 负责人:
- 金额:$ 68.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-04-15 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityAntibodiesAntigensArchivesAutoantibodiesAutoimmune ResponsesB-Cell ActivationB-LymphocytesBindingBiological AssayBloodBlood specimenBone MarrowBrainCD19 geneCNS autoimmune diseaseCell Culture TechniquesCellsCerebrospinal FluidClinicalCytoplasmCytoplasmic ProteinDataDiagnosisDiseaseEarly treatmentElectrophysiology (science)EncephalitisEventEvolutionExhibitsFamilyGene FamilyGenesGeneticHealthHomeHumanImmune responseImmunologicsImpairmentIndividualInflammationInflammatoryLaboratoriesLesionLifeMagnetic Resonance ImagingMediatingMemory B-LymphocyteMolecular TargetMultiple SclerosisMyelinNatureNeuraxisNeurologicNeuronsPathologyPathway interactionsPatient CarePatientsPhenotypePlasma CellsPlasmablastPopulationProcessRadiology SpecialtyRoleSamplingSpinal Cord LesionsSymptomsSyndromeTestingTherapeuticTimeTransverse Myelitisautoreactivitybasecell typecellular targetingclinical Diagnosiscohortdesignexperiencegenetic signaturegray matterhigh riskindividual patientinsightmultiple sclerosis patientneurotoxicityneutralizing antibodynext generation sequencingnovelperipheral bloodpreventprogramsrepositoryresponsesextranscriptometranscriptome sequencingwhite matter
项目摘要
PROJECT SUMMARY
Clinically Isolated Syndrome (CIS) patients experiencing their first neurological clinical episode related to Central
Nervous System (CNS) inflammation represent a unique opportunity to study the earliest immunological events
associated with CNS inflammation prior to treatment initiation. Our laboratory has acquired the largest human
sample repository of CIS patients experiencing their first clinical episode. Our preliminary data using state-of-
the-art cellular and genetic phenotyping demonstrate extensive B cell dysregulation within our untreated, CIS
cohort compared to controls including an expanded population of a B cell subtype called CD27high plasmablasts
in the cerebrospinal fluid (CSF) and peripheral blood at the time of their first documented clinical attack. In fact,
those patients with CD27high plasmablast expansion at the time of their first clinical attack were the only ones
who had documented exacerbations over the next two years. In addition, circulating CD27high plasmablasts
utilizing particular antibody genes tend to produce antibodies that bind neuronal antigens. These findings have
prompted us to question whether CD27high plasmablasts are involved in the autoreactivity associated with this
subset of CIS patients at high risk to convert to MS at the time of their first documented clinical attack. We are
also investigating whether Radiologically Isolated Syndrome (RIS) patients, who display CNS inflammation
similar to CIS patients but without clinical symptoms also exhibit expansion of CD27high plasmablasts that
produce anti-neuronal antibodies. The focus of this project will facilitate new mechanistic insights into the
contribution of CD27high plasmablasts in early CNS inflammation.
项目摘要
临床孤立综合征(CIS)患者首次发生与中枢神经系统相关的神经系统临床发作
神经系统(CNS)炎症是研究最早期免疫学事件的独特机会
治疗开始前与CNS炎症相关。我们的实验室获得了世界上最大的
CIS患者经历他们的第一次临床发作的样本库。我们使用状态的初步数据
最先进的细胞和遗传表型分析表明,在我们的未经治疗的CIS患者中,
与对照组相比的队列,包括称为CD 27高浆母细胞的B细胞亚型的扩增群体
在他们第一次记录的临床发作时,脑脊液(CSF)和外周血中的事实上,
在首次临床发作时具有CD27高水平浆母细胞扩增的患者是唯一的
他们在接下来的两年里记录了病情的恶化。此外,循环中的CD 27高浆母细胞
利用特定的抗体基因倾向于产生结合神经元抗原的抗体。这些发现
提示我们质疑CD27高浆母细胞是否参与与此相关的自身反应性。
CIS患者在首次记录临床发作时转化为MS的高风险子集。我们
还调查了放射性孤立综合征(RIS)患者,
与CIS患者相似但没有临床症状的患者也表现出CD27高浆母细胞的扩增,
产生抗神经元抗体。该项目的重点将促进新的机械见解,
CD27高浆母细胞在早期CNS炎症中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NANCY L MONSON其他文献
NANCY L MONSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NANCY L MONSON', 18)}}的其他基金
Contribution of plasmablasts in the conversion of transverse myelitis to multiple sclerosis
浆母细胞在横贯性脊髓炎转化为多发性硬化症中的作用
- 批准号:
10376290 - 财政年份:2018
- 资助金额:
$ 68.47万 - 项目类别:
相似海外基金
Rationally guided discovery platform for monoclonal antibodies against carbohydrate antigens using virus-like particle conjugate immunization and high throughput selection
使用病毒样颗粒缀合物免疫和高通量选择的合理引导的针对碳水化合物抗原的单克隆抗体的发现平台
- 批准号:
10574738 - 财政年份:2023
- 资助金额:
$ 68.47万 - 项目类别:
Assessing the role of liver stage antigens-specific antibodies against Plasmodium falciparum liver stage infection
评估肝期抗原特异性抗体对抗恶性疟原虫肝期感染的作用
- 批准号:
10392870 - 财政年份:2021
- 资助金额:
$ 68.47万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
10092930 - 财政年份:2020
- 资助金额:
$ 68.47万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
9896170 - 财政年份:2020
- 资助金额:
$ 68.47万 - 项目类别:
Interrogation of cell surface antigens on B lineage cells using structurally unique variable lymphocyte receptor antibodies of the evolutionarily distant sea lamprey
使用进化遥远的海七鳃鳗结构独特的可变淋巴细胞受体抗体询问 B 谱系细胞上的细胞表面抗原
- 批准号:
433456 - 财政年份:2020
- 资助金额:
$ 68.47万 - 项目类别:
Operating Grants
Investigations of interactions between various natural antibodies and food-derived antigens
研究各种天然抗体与食物源性抗原之间的相互作用
- 批准号:
19K15765 - 财政年份:2019
- 资助金额:
$ 68.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Identifying Kawasaki Disease-Specific Antibodies and Antigens
识别川崎病特异性抗体和抗原
- 批准号:
9932769 - 财政年份:2018
- 资助金额:
$ 68.47万 - 项目类别:
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
BB/P504713/1 - 财政年份:2017
- 资助金额:
$ 68.47万 - 项目类别:
Training Grant
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
1932904 - 财政年份:2017
- 资助金额:
$ 68.47万 - 项目类别:
Studentship
SBIR Phase II: Automated Design Methods of Antibodies Directed to Protein and Carbohydrate Antigens
SBIR II 期:针对蛋白质和碳水化合物抗原的抗体的自动化设计方法
- 批准号:
1632399 - 财政年份:2016
- 资助金额:
$ 68.47万 - 项目类别:
Standard Grant